MESTINON LP 180 mg, extended-release tablet 50 tablets
Active ingredients: Pyridostigmine bromide
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MESTINON LP 180 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 50 comprimé(s)
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Dec 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68333755CIP73001758CIP133400930017586Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMURE DE PYRIDOSTIGMINEcomprimé | 180 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.